HIGH

Camber Ketorolac Tromethamine Injection Recall 2025 for Glass Particulates

Camber Pharmaceuticals recalled Ketorolac Tromethamine Injection, USP, 60 mg/2 mL, 2 mL single-dose vials distributed nationwide in the United States. The recall is due to the presence of glass particulates. Healthcare providers and patients should stop using the product immediately and contact Aspiro Pharma Limited at 1-866-495-1995 for guidance.

Quick Facts at a Glance

Recall Date
October 1, 2025
Hazard Level
HIGH
Brands
Ketorolac Tromethamine, Camber Pharmaceuticals
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Presence of Particulate Matter: Particulate matter identified as glass

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Aspiro Pharma Limited or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Ketorolac Tromethamine Injection is used under medical supervision for short-term pain relief. It is supplied in 2 mL single-dose vials for intramuscular use.

Why This Is Dangerous

The presence of glass particulates in an injectable drug could cause tissue injury or other health risks if administered.

Industry Context

This recall is not described as part of a broader industry pattern in the notice.

Real-World Impact

If exposed, patients may need medical evaluation for potential glass-related injury and may require alternative analgesia.

Practical Guidance

How to identify if yours is affected

  1. Check the carton for NDC 31722-307-25
  2. Check the vial label for NDC 31722-307-02
  3. Review lot numbers AS1240347A, AS1240144A, AS1240145A, AS1240146A, AS1250295A
  4. Check expiration dates 09/2026, 05/2026, 06/2026, 05/2027
  5. If affected, stop use and contact Aspiro Pharma Limited at 1-866-495-1995

Where to find product info

NDC numbers on carton and vial labels; Lot numbers on vial label; Expiration dates on packaging

What timeline to expect

Recall processing and replacement timelines not specified. Expect manufacturer guidance.

If the manufacturer is unresponsive

  • Document all communications with the manufacturer
  • Contact FDA MedWatch at 1-800-FDA-1088 to file a consumer complaint
  • Consult your healthcare provider for alternatives

How to prevent similar issues

  • Before receiving injectable drugs, verify NDC and lot numbers
  • Check recall databases for updates on products
  • Work with a trusted pharmacy and healthcare provider to verify drug safety

Documentation advice

Keep the recall notice, packaging, lot numbers, dates, and all correspondence with the manufacturer for records.

Product Details

Product: Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL). Form: 2 mL single-dose vial. Route: Intramuscular. Rx only. Sold for Camber Pharmaceuticals, Inc., Piscataway, NJ 08854. Manufactured by Aspiro Pharma Limited, Telangana - 502281, INDIA. NDC 31722-307-25 (Carton); 31722-307-02 (Vial label). Lots: AS1240347A, AS1240144A, AS1240145A, AS1240146A, AS1250295A. Exp: 09/2026, 05/2026, 06/2026, 05/2027. Recall date: 2025-10-01. Status: ACTIVE. Distribution: Nationwide in the United States. Contact: 1-866-495-1995. FDA recall number: D-0036-2026.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • NDC on carton: 31722-307-25
  • Vial label NDC: 31722-307-02
  • Lot numbers: AS1240347A, AS1240144A, AS1240145A, AS1240146A, AS1250295A
  • Expirations: 09/2026, 05/2026, 06/2026, 05/2027
  • Recall status: ACTIVE
  • Distribution: Nationwide in the U.S.

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
LACERATIONOTHER

Product Classification

Product TypeKetorolac Tromethamine Injection, 60 mg/2 mL, 2 mL single-dose vial, IM use
Sold At
Multiple Retailers

Product Details

Model Numbers
AS1240347A
AS1240144A
AS1240145A
AS1240146A
AS1250295A
+2 more
UPC Codes
31722-305
31722-306
31722-307
+5 more
Affected States
ALL
Report Date
October 29, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more